Open Access
Issue
OCL
Volume 22, Number 2, March-April 2015
Article Number D205
Number of page(s) 6
Section Dossier: Dietary cholesterol: friend or foe? / Cholestérol alimentaire : ami ou ennemi ?
DOI https://doi.org/10.1051/ocl/2014051
Published online 10 March 2015
  • ANSES. 2014. Avis de l’Anses Saisine No. 2010-SA-0057: 1–15. [Google Scholar]
  • ANSES. 2014. Rapport d’expertise collective: Evaluation du risque et du bénéfice liés à la consommation de produits alimentaires enrichis en phytostérols ou en phytostanols 1–138. [Google Scholar]
  • Banuls C, Martinez-Triguero ML, Lopez-Ruiz A, et al. 2011. Serum lipid responses to phytosterol-enriched milk in a moderate hypercholesterolemic population is not affected by apolipoprotein E polymorphism or diameter of low-density lipoprotein particles. Eur. J. Clin. Nutr. 65: 255–261. [CrossRef] [PubMed] [Google Scholar]
  • De Castro-Orós I, Pampín S, Cofán M, et al. 2011. Promoter variant -204A °C of the cholesterol 7α-hydroxylase gene: Association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin. Nutr. 30: 239–246. [CrossRef] [PubMed] [Google Scholar]
  • De Smet E, Mensink RP, Plat J. 2012. Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present. Mol. Nutr. Food Res. 56: 1058–72. [CrossRef] [PubMed] [Google Scholar]
  • Geelen A, Zock PL, de Vries JH, Katan MB. 2002. Apolipoprotein E polymorphism and serum lipid response to plant sterols in humans. Eur. J. Clin. Invest. 32: 738–742. [CrossRef] [PubMed] [Google Scholar]
  • Genser B, Silbernagel G, De Backer G, et al. 2012. Plant sterols and cardiovascular disease: a systematic review and meta-analysis. Eur. Heart J. 33: 444–451. [CrossRef] [PubMed] [Google Scholar]
  • Guardamagna O, Abello F, Baracco V, et al. 2011. Primary hyperlipidemias in children: Effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption. Acta Diabetol 48: 127–133. [CrossRef] [PubMed] [Google Scholar]
  • Gylling H, Hallikainen M, Raitakari OT, et al. 2009. Long-term consumption of plant stanol and sterol esters, vascular function and genetic regulation. Br. J. Nutr. 101: 1688–1695. [CrossRef] [PubMed] [Google Scholar]
  • Ishiwata K, Homma Y, Ishikawa T, Nakamura H, Handa S. 2002. Influence of apolipoprotein E phenotype on metabolism of lipids and apolipoproteins after plant stanol ester ingestion in Japanese subjects. Nutrition 18: 561–565. [CrossRef] [PubMed] [Google Scholar]
  • Jakulj L, Trip MD, Sudhop T, Von Bergmann K,Kastelein JJP, Vissers MN. 2005. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: Effects on plasma lipid levels. J. Lipid Res. 46: 2692–2698. [CrossRef] [PubMed] [Google Scholar]
  • Kratz M, Kannenberg F, Gramenz E, et al. 2007. Similar serum plant sterol responses of human subjects heterozygous for a mutation causing sitosterolemia and controls to diets enriched in plant sterols or stanols. Eur. J. Clin. Nutr. 61: 896–905. [CrossRef] [PubMed] [Google Scholar]
  • Kwiterovich Jr PO, Chen SC, Virgil DG, Schweitzer A, Arnold DR, Kratz LE. 2003. Response of obligate heterozygotes for phytosterolemia to a low-fat diet and to a plant sterol ester dietary challenge. J. Lipid Res. 44: 1143–1155. [CrossRef] [PubMed] [Google Scholar]
  • Lottenberg AM, Nunes VS, Nakandakare ER, et al. 2003. The human cholesteryl ester transfer protein I405V polymorphism is associated with plasma cholesterol concentration and its reduction by dietary phytosterol esters. J. Nutr. 133: 1800–1805. [PubMed] [Google Scholar]
  • Mensink RP, de Jong A, Lutjohann D, Haenen GR, Plat J. 2010. Plant stanols dose-dependently decrease LDL-cholesterol concentrations, but not cholesterol-standardized fat-soluble antioxidant concentrations, at intakes up to 9 g/d. Am. J. Clin Nutr. 92: 24–33. [CrossRef] [PubMed] [Google Scholar]
  • Miettinen TA, Vanhanen H. 1994. Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 105: 217–226. [CrossRef] [PubMed] [Google Scholar]
  • Moruisi KG, Oosthuizen W, Opperman AM. 2006. Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J. Am. Coll. Nutr. 25: 41–48. [CrossRef] [PubMed] [Google Scholar]
  • Myrie SB, Mymin D, Triggs-Raine B, Jones PJH. 2012. Serum lipids, plant sterols, and cholesterol kinetic responses to plant sterol supplementation in phytosterolemia heterozygotes and control individuals. Am. J. Clin. Nutr. 95: 837–844. [CrossRef] [PubMed] [Google Scholar]
  • Naumann E, Plat J, Kester AD, Mensink RP. 2008. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J. Am. Coll. Nutr. 27: 117–126. [CrossRef] [PubMed] [Google Scholar]
  • Othman RA, Myrie SB, Jones PJ. 2013. Non-cholesterol sterols and cholesterol metabolism in sitosterolemia. Atherosclerosis 231: 291–299. [CrossRef] [PubMed] [Google Scholar]
  • Plat J, Bragt MCE, Mensink RP. 2005. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. J. Lipid Res. 46: 68–75. [CrossRef] [PubMed] [Google Scholar]
  • Plat J, Mensink RP. 2002. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur. J. Clin Invest. 32: 242–250. [CrossRef] [PubMed] [Google Scholar]
  • Plat J, Mensink RP. 2005. Plant Stanol and Sterol Esters in the Control of Blood Cholesterol Levels: Mechanism and Safety Aspects. Am. J. Cardiol. 96: 15–22. [CrossRef] [Google Scholar]
  • Ras RT, Geleijnse JM, Trautwein EA. 2014. LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br. J. Nutr. 112: 214–219. [CrossRef] [PubMed] [Google Scholar]
  • Ras RT, Hiemstra H, Lin Y, Vermeer MA, Duchateau GS, Trautwein EA. 2013. Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations–a meta-analysis of randomized controlled studies. Atherosclerosis 230: 336–346. [CrossRef] [PubMed] [Google Scholar]
  • Rideout TC, Harding SV, Mackay D, Abumweis SS, Jones PJ. 2010. High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy. Am. J. Clin. Nutr. 92: 41–46. [CrossRef] [PubMed] [Google Scholar]
  • Sanchez-Muniz FJ, Maki KC, Schaefer EJ, Ordovas JM. 2009. Serum lipid and antioxidant responses in hypercholesterolemic men and women receiving plant sterol esters vary by apolipoprotein E genotype. J. Nutr. 139: 13–19. [CrossRef] [PubMed] [Google Scholar]
  • Silbernagel G, Chapman MJ, Genser B, et al. 2013. High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysis. J. Am. Coll. Cardiol. 62: 291–299. [CrossRef] [PubMed] [Google Scholar]
  • Stalenhoef AF, Hectors M, Demacker PN. 2001. Effect of plant sterol-enriched margarine on plasma lipids and sterols in subjects heterozygous for phytosterolaemia. J. Intern. Med. 249: 163–166. [CrossRef] [PubMed] [Google Scholar]
  • Tammi A, Ronnemaa T, Miettinen TA, et al. 2002. Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant stanol esters in children: the STRIP study. Special Turku Coronary Risk Factor Intervention Project. Acta Paediatr 91: 1155–1162. [CrossRef] [PubMed] [Google Scholar]
  • Teupser D, Baber R, Ceglarek U, et al. 2010. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ. Cardiovasc. Genet. 3: 331–339. [CrossRef] [PubMed] [Google Scholar]
  • Thomsen AB, Hansen HB, Christiansen C, Green H, Berger A. 2004. Effect of free plant sterols in low-fat milk on serum lipid profile in hypercholesterolemic subjects. Eur. J. Clin Nutr. 58: 860–870 [CrossRef] [PubMed] [Google Scholar]
  • Vanhanen HT, Blomqvist S, Ehnholm C, et al. 1993. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J. Lipid Res. 34: 1535–1544. [PubMed] [Google Scholar]
  • Vergès B, Athias A, Petit JM, Brindisi MC. 2009. Extravascular lipid deposit (xanthelasma) induced by a plant sterol-enriched margarine. BMJ Case Reports doi:10.1136/bcr.10.2008.1108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21822448. [Google Scholar]
  • Vergès B, Fumeron F. Potential risks associated with increased plasma plant sterol levels. Diabetes Metab 2015, sous presse. [Google Scholar]
  • Weingärtner O, Baber R, Teupser D. 2014. Plant sterols in food: no consensus in guidelines. Biochem. Biophys. Res. Commun. 446: 811–813. [CrossRef] [PubMed] [Google Scholar]
  • Zhao HL, Houweling AH, Vanstone CA, et al. 2008. Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men. Lipids 43: 1155–1164. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.